Thromboxane A2 synthesizing activity of platelets in coronary artery diseases.

Thromboxane A synthase enhances blood flow recovery from hindlimb ischemia

“…40 Furthermore, the enhancement of TXA 2 synthesis related to the incidence of coronary artery disease. 41 A TP agonist I-BOP (CAS 128719-90-4[1S-[1a,2a(Z),3b(1E,3S*),4a]]-7-[3-[3-hydroxy-4-(4-iodophenoxy)-1-butenyl]-7-oxabicyclo [2.2.1]hept-2-yl]-5-heptenoic acid) increased the beating rate and suppressed in TP À/À . 18 TXAS and TXA 2 were reported to be a strong positive regulator for blood vessel growth.…”